The 4 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +968.97% increase from the last price of 1.45.
The current consensus among 4 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.53
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.